16 Sep 2019 --- Awareness of the importance of clinical evidence for new products is rising as pharmaceutical companies move toward nutraceuticals and consumer demand for quality products becomes more pronounced. NutritionInsight speaks with PharmaLinea’s Chairman and Founder, Blaž Gorjup, about how the private label food supplement provider sets itself apart in the market by conducting its own clinical substantiation of supplements – an act that is rare, if not non-existent, for a private label provider. However, he notes that the future market landscape could mean clinical substantiation of finished products will become a necessity for companies from all backgrounds, not only pharmaceutical.
